Report Fraud About Us What We Do

Consumer News

Mylan Recalls Ulcer Drug Contaminated With Cancer-Causing NDMA

Another drugmaker is recalling heartburn meds due to a possible cancer-causing agent found in the pills.

Mylan N.V. is recalling three lots of nizatidine, a medicine used to treat duodenal ulcers and acid reflux disease. Trace amounts of NDMA, a cancer-causing agent were found in the drug. The drug was manufactured by Solara Active Pharma Sciences Limited.

The recall comes just a few months after Sanofi recalled its over-the-counter heartburn drug Zantac due to a possible contamination with NDMA.

The FDA has shared preliminary results of other antacids it deemed carcinogen-free.

Interested in posts like these? Stay up to date with our newsletter!

No thoughts on “Mylan Recalls Ulcer Drug Contaminated With Cancer-Causing NDMA” yet. Be the first to speak your mind!

Leave a Reply